|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2000-4-4
|
|
pubmed:abstractText |
To investigate the suitability of lutetium texaphyrin (lu-tex) as a fluorescence imaging agent in the delineation of retinal vascular and choroidal vascular diseases. The utilization of an efficient fluorescent molecule that is also a photosensitizer represents a unique opportunity to couple diagnosis and therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0002-9394
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
129
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
353-62
|
|
pubmed:dateRevised |
2010-3-23
|
|
pubmed:meshHeading |
pubmed-meshheading:10704552-Animals,
pubmed-meshheading:10704552-Choroid,
pubmed-meshheading:10704552-Choroidal Neovascularization,
pubmed-meshheading:10704552-Disease Models, Animal,
pubmed-meshheading:10704552-Fluorescein,
pubmed-meshheading:10704552-Fluorescein Angiography,
pubmed-meshheading:10704552-Fundus Oculi,
pubmed-meshheading:10704552-Indocyanine Green,
pubmed-meshheading:10704552-Lutetium,
pubmed-meshheading:10704552-Male,
pubmed-meshheading:10704552-Metalloporphyrins,
pubmed-meshheading:10704552-Photochemotherapy,
pubmed-meshheading:10704552-Photosensitizing Agents,
pubmed-meshheading:10704552-Rabbits,
pubmed-meshheading:10704552-Retinal Neovascularization,
pubmed-meshheading:10704552-Retinal Vessels
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Lutetium texaphyrin (Lu-Tex): a potential new agent for ocular fundus angiography and photodynamic therapy.
|
|
pubmed:affiliation |
Pharmacyclics Inc, Sunnyvale, CA, USA. mu.msb@forsythe.stanford.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
